Sulfonylurea (Glipizide/Glyburide) ƒe agbɔsɔsɔ si gbɔ eme: Nusita Ʋumesukli Gblẽna Enuenu Le Glucose megbe¶

Sulfonylureas - siwo dometɔ aɖewoe nye glipizide (Glucotrol, Glucotrol XL), glyburide / glibenclamide (DiaBeta, Glynase, Micronase), glimepiride (Amaryl), gliclazide (Diamicron), kple chlorpropamide - kpakple meglitinides siwo wɔa dɔ kabakaba (repaglinide [Prandin] kple nateglinide [Starlix]) nye suklidɔ ƒomevi eve ƒe atike siwo woano siwo woyɔna be insulin secretagogues. To vovo na metformin (si wɔa dɔ to insulin ƒe dɔwɔwɔ nyuie wu me eye meɖea sukli si le ʋu me dzi kpɔtɔna wu alesi wòle le ame si le lãmesẽ me gbeɖe o kloe) la, sulfonylureas blana ɖe Sulfonylurea Receptor-1 (SUR1) potassium si sea veve ɖe ATP nu ƒe akpa sue aɖe (K-ATP) mɔ̃wo ɖe dɔgboa ƒe beta lãmenugbagbeviwo dzi, si zi dɔgboa dzi be wòatsɔ insulin si le lãme na ame ƒe ƒutsotsoe gã siwo yia edzi la aƒu gbe ɖe ʋukawo me eɖanye aleke gbegbee dɔnɔa ƒe ʋumesukli ɖiɖi o. Eyata sulfonylureas le ɖeviwo ƒe "Atikekui Ðeka Ate Ŋu Awu" ƒe xexlẽdzesi me: ɖeka 5 mg alo 10 mg glipizide alo glyburide ƒe atikekui si ɖevi si le zɔzɔm mi le vo me - alo gbesiagbe agbɔsɔsɔme si wozãna ɖaa si ƒoa ƒu ɖe ame tsitsi aɖe ŋu le ayiku ƒe abi sesẽ alo atikewo ƒe kadodo ta (abe trimethoprim-sulfamethoxazole [Bactrim] alo fluconazole) - hea ahɔhɔ̃mekawo ƒe agbɔsɔsɔ si de to, si nɔa anyi didi, si hea agbe, vɛ, alɔ̃madɔmadɔ, ahɔhɔ̃ ƒe gbegblẽ tegbee, kple alɔ̃madɔmadɔ si nɔa anyi gaƒoƒo 24 va ɖo 72+. Nusi gavloe wue nye be woawɔ nu ɖe sulfonylurea ƒe agbɔsɔsɔ si gbɔ eme ŋu abe insulin ƒe dɔwɔwɔ dzro aɖe ene to Intravenous Dextrose (D50W alo D25W) ɖeɖe dzaa hea suklidɔ ƒe mɔ̃ vɔ̃ɖi si gbugbɔna doa goe: suklidɔ si wodona ɖe ʋuka me ƒe dzidziɖedzi ɖesiaɖe ʋãa dɔgbo si wotsɔ sulfonylurea wɔe la be wòaɖe insulin ƒe dzidziɖedzi si lolo wu gɔ̃ hã ɖe go, si wɔnɛ be sukli si le ʋu me gaɖiɖina va ɖoa agbɔsɔsɔ si wua ame (< 30 mg/dL alo < 1.7 mmol/L) Aɖabaƒoƒo 30 va ɖo 60 megbe negbe ɖe atikewɔlawo na atikewɔtike tɔxɛ si wozãna tsɔ daa dɔlékuiwutike si nye Octreotide (Sandostatin), enumake be woatsɔ axe mɔ ɖe insulin ƒe dodo le dɔgboa me nu le afisi wòtso.

Ne ɖevi aɖe mi suklidɔtike ɖeka gɔ̃ hã, alo ne ame tsitsi aɖe si le glipizide, glyburide, glimepiride, alo gliclazide nom la tɔtɔ, fifia le ʋuʋum, le ʋuʋum, le avu wɔm, eƒe nuƒoƒo me mekɔ o, alo megate ŋu wɔa nu kpata o la, ƒo ka na wò nutoa me ƒe xexlẽdzesi kpata (911 le United States kple Canada, 112 le Europa Dukɔwo ƒe Habɔbɔ bliboa me, 999 le dukɔwo dome United Kingdom) to míaƒe xexlẽdzesi siwo wozãna kpata directory enumake, eye nàto eme suklidɔ ƒe nɔnɔme kpatawo, . suklidɔ ƒe ketoacidosis kple hyperosmolar nɔnɔme, kple seizure ƒe kpekpeɖeŋunadɔ gbãtɔ.

Wɔ esia fifia¶

1. Ƒo ka na 911 / 112 / 999 kple Poison Control enumake eye nàlé ŋku ɖe asibidɛ ƒe ʋumesukli ŋu ne mita le asiwò: Ne dɔnɔa le alɔ̃ dɔm, tɔtɔ, eƒe nyawo le ɣli dom, le nu lém, alo meɖoa nya ŋu o la, yɔ Advanced Life Support (ALS) ambulance enumake. Ne ɖevi si le zɔzɔm alo ɖevi sue aɖe ate ŋu mi sulfonylurea alo meglitinide atikekui ÐEKA gɔ̃ hã (glipizide, glyburide/glibenclamide, glimepiride, gliclazide, repaglinide), tsɔ wo yi dɔwɔƒe si kpɔa nudzɔdzɔ kpatawo gbɔ enumake - ɖeviwo ƒe sulfonylurea nono ɖesiaɖe bia be woaxɔ wo ɖe kɔdzi gaƒoƒo 24 sɔŋ elabena suklidɔ sesẽ ate ŋu adze ame dzi kpata gaƒoƒo 8 va ɖo 18 le atikekui la mimi vɔ megbe (vevietɔ ne ɖevia le alɔ̃ dɔm le zã me).
2. Ne amea NYA eye wòte ŋu mia nu dedie la, na sukli si wɔa dɔ kabakaba KPLƆ numeɖenu si me carbohydrate/protein sesẽ aɖe le enumake: Nae 15 to 20 grams ƒe sukli si wɔa dɔ kabakaba ( .120 mL [4 oz] ƒe atikutsetse me tsi alo soda si menye nuɖuɖu o si wozãna edziedzi, sukli ƒe atikekui 3 va ɖo 4, alo anyitsi/sukli si wotsɔ ƒo tsi me agbɔsɔsɔme 1), eye nàtsɔ numeɖenu si me carbohydrate kple protein le si me nu sesẽwo le (abe peanut butter crackers alo cheese sandwich ene) akplɔe ɖo enumake. Mègatsɔ nuɖuɖu, detsiƒonu, alo gel de ame si le alɔ̃ dɔm, si le alɔ̃ dɔm, alo ame si ƒe tagbɔ le gbegblẽm la ƒe nu me gbeɖe o.
3. Se nusita Glucagon ƒe atikewo (GlucaGen, Baqsimi, Gvoke) zi geɖe doa kpo nu alo gagblẽa nu le rebound crashes ŋu le Sulfonylurea aɖi me: Ne amea ƒe tagbɔ megale dɔ wɔm o eye IV aɖeke meli haɖe o la, àte ŋu azã Glucagon kit si wozãna kpata le lãmeka me alo no me ne ɖeka le asiwò. Gake xlɔ̃ nu kpekpeɖeŋunalawo be glucagon ɖoa ŋu ɖe aklã me glycogen ƒe nudzraɖoƒewo ŋu (siwo nu yina kabakaba le sulfonylurea ƒe agbɔsɔsɔ si gbɔ eme me) EYE glucagon ʋãa dɔgbo ƒe beta lãmenugbagbeviwo tẽ be woaɖe insulin GEÐE ɖa, si wɔnɛ zi geɖe la, suklidɔ ƒe ɖiɖi sesẽ si gbugbɔna dzɔna le miniti 30 va ɖo 45 me.
4. Xlɔ̃ nu kpekpeɖeŋunalawo kple ɖɔkta siwo le xɔ si me wowɔa dɔ kpata le tso "IV Dextrose Rebound Trap" ŋu eye nàbia OCTREOTIDE: Gblɔ na atikewɔlawo ƒe ƒuƒoƒoa be: "Esia nye Sulfonylurea (Glipizide / Glyburide / Glimepiride) ƒe agbɔsɔsɔ si gbɔ eme - D50W bolus zazã enuenu ɖeɖeko ahe insulin ƒe dzidziɖedzi si gbugbɔna vɛ; taflatse dze Subcutaneous alo Intravenous gɔme Octreotide le sukli si le ʋu me si bɔbɔ la ɖɔɖɔɖo vɔ megbe teti."
5. MÈGAxe mɔ ɖe nuɖuɖu nu na ɖevi si me dzesi aɖeke mele o si le lalam le ŋkuléle ɖe eŋu le kɔdzi o: Ne woxɔ ɖevi ɖe kɔdzi hena gaƒoƒo 24 ƒe ŋkuléle ɖe eŋu le sulfonylurea-tike mimi vɔ megbe la, na ɖevia naɖu nuɖuɖu si sɔ esime nèle abadzivɔ ƒe asibidɛ ƒe ʋumesukli me dzrom gaƒoƒo 1 va ɖo 2 ɖesiaɖe. Gake mègadze mɔxexeɖedɔléle nu ƒe dextrose si wodona ɖe ʋuka me gɔme o (D5W alo D10W) tsia ɖevi si me dzesi aɖeke mele o si ƒe sukli sɔ le ʋu me, elabena sukli si wotsɔ xea mɔ na ʋu me ɣlana ne ɖevia mi atikekui la ŋutɔŋutɔ vaseɖe esime woatsi tsi si le dodom la eye woaɖo ɖevia ɖe aƒeme wòadze afɔku si wua ame me.
6. Kpɔ dɔnɔa ƒe atikekui bubuwo ɖa be "Hidden Sulfonylurea Multipliers": Tsɔ atikekui ƒe aŋetu ɖesiaɖe va kɔdzi. Le ame tsitsi siwo ŋu suklidɔ Ƒomevi 2 le gome la, sulfonylurea coma si ate ŋu ade woƒe agbe afɔku me la dzɔna zi geɖe menye to atikekui bubuwo nono me o, ke boŋ ne wodze dɔlékuiwutike alo dɔlékuiwutike (Trimethoprim-Sulfamethoxazole [Bactrim/Septra], Fluconazole [Diflucan], Ciprofloxacin/Levofloxacin, alo Clarithromycin) alo ayiku ƒe abi sesẽ (AKI), si xea mɔ na glyburide alo glimepiride metabolite siwo le dɔ wɔm ƒe ɖeɖeɖa.

Nyametsotsoti: Ðeviwo kple ame tsitsiwo ƒe sulfonylurea / meglitinide ƒe agbɔsɔsɔ fũ dzi kpɔkpɔ kple Octreotide¶

flowchart TD
    Start["Wosusu be Sulfonylurea (Glipizide, Glyburide/Glibenclamide, Glimepiride, Gliclazide) alo Meglitinide (Repaglinide, Nateglinide) ƒe agbɔsɔsɔ si gbɔ eme / Nuƒoƒoƒu"] --> CheckBG{"Kpɔ STAT Abati ƒe Asibide & Lab Serum Glucose ɖa"}

    CheckBG -->|Hypoglycemic: Blood Glucose < 60-70 mg/dL (< 3.3-3.9 mmol/L) OR Any Neuroglycopenic Symptoms (Confusion, Diaphoresis, Seizures, Coma)| TreatHypo["1. Immediate Glucose Restoration: - Awake/Alert: Oral Glucose (15-20 g) + Complex Carbohydrate Meal - Altered/Unconscious: IV Dextrose Bolus (Adults: D50W 50 mL [25 g]; Children: D25W 2-4 mL/kg OR D10W 5-10 mL/kg [0.5-1 g/kg]) 2. Administer Activated Charcoal (1 g/kg) if < 1-2 Hours Post-Ingestion (Or up to 4-6h for Extended-Release Glipizide XL)"]

    CheckBG -->|Euglycemic & Asymptomatic: Blood Glucose >= 70 mg/dL (>= 3.9 mmol/L)| ObserveProtocol["1. Activated Charcoal (1 g/kg) ne < Gaƒoƒo 1-2 le eɖuɖu vɔ megbe 2. Ðe mɔ na Nuɖuɖu si Wonona Nyuie; MÈGAdze Prophylactic IV Dextrose alo Octreotide (Masks Onset) gɔme o 3. NUSIWO WOKPƆ BE WOAŊLƆ ÐE GLUCOSE ƑE NUÐEÐEŊUTI ME KPLE Q1-2H GLUCOSE CHECKS: - Ðeviwo ƒe Nuɖuɖuwo Katã & Ame Tsitsiwo ƒe Extended-Release / Glyburide: Woxɔe ɖe xɔa me hena Gaƒoƒo 24 Ya teti (Elɔ Zã Alɔ̃dɔdɔ hã le eme) - Ame Tsitsiwo ƒe Gbɔdɔdɔ Enumake Meglitinide (Repaglinide/Nateglinide): Gaƒoƒo 8-12 ya teti"]

    TreatHypo --> StartOctreotide["NUSIWO WOKPƆNA KPLE NUSIWO WOKPƆNA KPƆKPƆ: DZE OCTREOTIDE (SANDOSTATIN) GƆME LE HYPOGLYCEMIC EPISODE GBÃTƆ ME (Exea mɔ na Beta-Cell Voltage-Gated Calcium Channels be woatɔ te Rebound Insulin Release): - Ame tsitsiwo: 50 va ɖo 100 mcg Subcutaneous (SC) alo IV Gaƒoƒo 6 Ðesiaɖe (hena gaƒoƒo 24 ya teti) - Ðeviwo: 1 va ɖo 1.5 mcg/kg (Max 50 mcg) SC alo IV Gaƒoƒo 6 Ðesiaɖe (Alo IV dodo atraɖii le 50-125 ng/kg/min / 25-50 mcg/hr le Refractory Cases me)"]

    StartOctreotide --> MaintenanceCare["1. Du Dzadzraɖo IV Dextrose (D5W alo D10W) Titrated be Ʋu me Sukli Nanɔ 80-120 mg/dL (4.4-6.7 mmol/L) + Nu me Nuɖuɖu si Seɖoƒe Mele O Ne Nyɔ Zi ɖeka 2. Kpɔ Ʋu me Suklidɔ ɖa Aɖabaƒoƒo 30-60 Ðesiaɖe Vaseɖe esime Wòali ke, Emegbe Gaƒoƒo 2 Ðesiaɖe 3. Kpɔ Serum ɖa Creatinine, Potassium, & Insulin/C-Peptide ƒe Agbɔsɔsɔme (Ðo Kpe Endogenous Hyperinsulinemia: Insulin Kɔkɔ + C-Peptide Kɔkɔe)"]

    ObserveProtocol --> DelayedDrop{"Ðe Ʋumesukli Dzi Ðena < 60-70 mg/dL Le Teƒe Aɖe Le Ekpɔkpɔ Mea?"}
    DelayedDrop -->|YES| TreatHypo
    DelayedDrop -->|NO: 100% Euglycemic for 24 Full Hours Without IV Dextrose or Octreotide| SafeDischarge["Dedie na Dodo (Le Ðeviwo ƒe Mɔxexeɖedɔléle / Tagbɔdɔléle alo Ayikuwo ƒe Atikewo ƒe Asitɔtrɔ megbe)"]

    MaintenanceCare --> WeanProtocol["GAƑOƑO 24 ƑE OCTREOTIDE GBÃTƆ ƑE SE SI WOÐO BE: Ne èdzudzɔ Octreotide & IV Dextrose vɔ la, Lé ŋku ɖe Dɔnɔa Ŋu le Kɔdzi le Nuɖuɖu Siwo Wonona Ðeka Ko Me Gaƒoƒo 12 Va ɖo 24 Bliboe Be Nàɖo kpe edzi be Megadzɔ Tsitsi Megbe O (Vevietɔ le Ayiku ƒe Dɔmawɔmawɔ alo Glyburide/Glimepiride me)"]

Dɔlélenutsiŋutete: Alesi Sulfonylureas Tua Dɔgboa "Dzi" Kple Alesi Octreotide Trɔnae "Tsi".¶

1. Dɔgboa ƒe Beta-Lãmenugbagbeviwo ƒe Ʋuʋudedi (SUR1 -> K-ATP -> VGCC -> Insulin) .¶

Le dɔgbo si le lãmesẽ me la, ne sukli si le ʋu me dzi ɖe edzi le nuɖuɖu vɔ megbe ko hafi beta lãmenugbagbeviwo ɖea insulin ɖe go:

1. Normal Physiological Glucose Sensing: Ne ʋumesukli dzi ɖe edzi wu 80 to 90 mg/dL, sukli gena ɖe dɔgboa ƒe beta lãmenugbagbevi me to GLUT2 transporters eye wotrɔa asi le eŋu to glycolysis kple mitochondria me wòzua ATP. Lãmenugbagbeviwo me ATP-to-ADP ƒe xexlẽme si le dzidzim ɖe edzi la xea mɔ na ATP-sensitive potassium-mɔwo (K-ATP channels) le lãmenugbagbeviwo ƒe lãkusi dzi.
2. Depolarization kple Calcium ƒe gege ɖe eme: Elabena potassium ions siwo me dzoxɔxɔ nyui le (K+) megate ŋu doa go le lãmenugbagbevi la me o, beta-lãmenugbagbeviwo ƒe lãkusi depolarizes (ezua dzoxɔxɔ nyui). Elektrikŋusẽ ƒe vovototodedeameme sia ʋua L-ƒomevi Voltage-Gated Calcium Channels (VGCC), si ɖea mɔ na calcium si le lãmenugbagbeviwo godo (Ca2+) be wòatsi ɖe beta lãmenugbagbevi la me eye wòahe exocytosis (fusion and release) si nye insulin secretory granules siwo wowɔ do ŋgɔ (kple equimolar C-peptide) ɖe portal vein la me.
3. Alesi Sulfonylureas Hijack the Switch: Amesiame K-ATP channel nye octamer si wotu tso ʋuʋudedi ene siwo wɔa ** .Kir6.2** subunits siwo ƒo xlã ene siwo wɔa ɖoɖo ɖe Sulfonylurea Receptor-1 (SUR1) ƒe akpa suewo. Sulfonylureas (glipizide, glyburide, glimepiride, gliclazide) kple meglitinides (repaglinide, nateglinide) blana ɖe ** la ŋu tẽ.SUR1 subunit** kple mechanically lock la K-ATP channel shut, si to lãmenugbagbevi la ƒe ATP suklidɔlékui ƒe dzesi si sɔ ŋu keŋkeŋ. Ne dɔnɔa ƒe ʋumesukli ɖiɖi ŋutɔ va ɖo... 15 mg/dL eye lãmenugbagbeviwo me ATP ɖiɖina va ɖoa dɔwuame ƒe agbɔsɔsɔ, si nye K-ATP mɔ̃a nɔa tsitsim, calcium yia edzi nɔa gegem ɖe eme, eye beta lãmenugbagbevi la yia edzi nɔa insulin si wua ame ɖem doa goe esime wònɔa aklã me sukli ƒe dzɔdzɔ kple glycogenolysis tem ɖe to le ɣeyiɣi ɖeka me.

2. Nusita Octreotide Nye Lãmetsiŋusẽ Ŋuti Atike Deblibo (Downstream Calcium Blockade) .¶

Elabena sulfonylureas xea mɔ na... SUR1 / K-ATP mɔ̃ si le tsi si le tsia me la tame, si naa sukli geɖe wu (D50W) ko dzia lãmenugbagbeviwo me ATP ɖe edzi eye doa calcium ƒe gege ɖe lãme na ame kple insulin exocytosis ɖe ŋgɔ ne sulfonylurea ƒe agbɔsɔsɔ dze ɖiɖi alo ƒuƒu gɔme ko.

• Alesi Octreotide wɔa dɔe: Octreotide nye octapeptide si wowɔ si wɔa dɔ ɣeyiɣi didi si sɔ kple lãmetsi si nye somatostatin. Ne wodoe ɖe ŋutigbalẽ te alo to ʋuka me la, Octreotide blana ɖe Somatostatin Subtype-2 kple Subtype-5 (SSTR2 kple SSTR5) G-protein-coupled receptors le dɔgboa ƒe beta-lãmenugbagbeviwo ƒe lãkusi dzi.
• Tɔtrɔ Tsã le Downstream: Dɔwɔwɔ na SSTR2 / SSTR5 xea mɔ na calcium-mɔ̃ siwo ŋu elektrikŋusẽ le tẽ (VGCC) eye wòxea mɔ na adenylate cyclase (cAMP) kple insulin ƒe ʋeʋẽ si le didiƒe ʋĩ ƒe exocytosis. Elabena voltage-gated calcium mɔ̃wo nɔa anyi anyime le SUR1 / K-ATP channel, Octreotide xea mɔ na calcium ƒe gege ɖe eme eye wòtɔa insulin ƒe dodo keŋkeŋ esime sulfonylurea gakpɔtɔ bla ɖe... SUR1 xɔla.
• Alternative Second-Line Antidote (Diazoxide): Hafi Octreotide nava zu belélename ƒe dzidzenu la, atikewɔlawo zãa Diazoxide (Proglycem), si nye benzothiadiazine si meɖea tsinyegoe me o si ʋuna tẽ K-ATP mɔ̃wo dzi. Egbea la, wolɔ̃a Octreotide vevie wu Diazoxide elabena Diazoxide hea reflex tachycardia sesẽ, systemic hypotension, tsi ƒe léle ɖe te, kple ʋuʋudedi vɛ, gake Octreotide ya le ʋu ƒe dɔwɔwɔ me dedie, ele bɔbɔe be woanae to ŋutigbalẽ te (50 to 100 mcg SC Q6H), eye wòwɔa dɔ wu sã le suklidɔ ƒe ʋu ƒe sisi enuenu ɖeɖeɖa me.

Master Comparison Table: Suklidɔtike Siwo Wonona Le Wo Nono Me (Wo dometɔ Kawoe Hea Suklidɔ si Wua Ame?)¶

Esi wònye be dɔnɔ siwo ŋu suklidɔ Ƒomevi 2 le noa atike geɖe siwo woano enuenu ta la, atike ƒe hatsotso si tututu wono nyanyae afia ne suklidɔ si wua ame ate ŋu axɔ dɔnɔa:

Afɔɖeɖe ɖesiaɖe ƒe Kɔdzi Kple EMS ƒe Agbɔsɔsɔme Ŋuti Ðoɖowɔɖi: Dextrose, Octreotide, Kple Dekɔntabubu¶

1. Dextrose ƒe Ʋukawo Me Ðɔɖɔɖo Si Wotu Ðe Kpekpeme Dzi (Ƒo Asa na Extravasation Necrosis Kple Rebound Spikes) .¶

Ne dɔnɔ aɖe va kple suklidɔ si sulfonylurea hena vɛ (blood glucose < 60 mg/dL [3.3 mmol/L] alo ahɔhɔ̃mekawo ƒe suklidɔ ƒe dzesi ɖesiaɖe), agbugbɔ ahɔhɔ̃ me sukli si sɔ la aɖo te enumake to dextrose si wodona ɖe ʋuka me ƒe agbɔsɔsɔ si wɔa dɔ nyuie wu zazã me be wòaɖe ʋukawo ƒe dzikudodo dzi akpɔtɔ eye wòaɖo seɖoƒe na dɔgboa ƒe beta-lãmenugbagbeviwo ƒe ʋuʋu fũu akpa:

• Ame tsitsiwo: Na 25 to 50 mL ƒe 50% Dextrose (D50W, si me 12.5 to 25 grams ƒe sukli) to IV-ka si le dedie si le gota alo titina (alo 100 to 250 mL ƒe 10% Dextrose [D10W] si wodona kabakaba le miniti 5 va ɖo 10 me, si wɔnɛ be ʋumenugbagbeviɣidɔ mebɔna o eye suklidɔ ƒe ʋuʋu nɔa bɔbɔe wu D50W).
• Ðeviwo kple Ðevi Siwo Le Azɔli Dzi: Mègatutui gbeɖe o D50W ɖe ɖevi sue aɖe ƒe ʋuka si le gota me (eƒe hyperosmolarity si gbɔ eme [2,525 mOsm/L] hea vein sclerosis sesẽ kple lãmenugbagbeviwo ƒe ʋuʋu blibo vɛ ne eɖe ʋukawo me). Ke boŋ wɔ ɖe ɖeviwo ƒe "Se 50" (Dose in mL/kg x % Dextrose = 50, si tsɔa ** .0.5 grams/kg ƒe sukli**): .
• 10% Dextrose (D10W, si wolɔ̃na wu na vidzĩwo kple ɖevi suewo): Na ** .5 mL/kg (0.5 g/kg)** IV bolus (vaseɖe 10 mL/kg [1 g/kg] na suklidɔ ƒe alɔ̃madɔmadɔ sesẽwo).
• 25% Dextrose (D25W, ɖevi tsitsiwo): Na ** .2 mL/kg (0.5 g/kg)** yi 4 mL/kg (1 g/kg) IV bolus.
• Thiamine Co-Administration na Ame Tsitsi Siwo Mekpɔa Nu Nyuie O alo Ahatsunolawo: Le ame tsitsi siwo ŋu ahanono ƒe kuxi si nɔa anyi didi alo nunyuimakpɔɖui sesẽ le gome la, na ** .100 mg ƒe Intravenous Thiamine (Vitamin B1)** kpe ɖe (mehea ɖe megbe gbeɖe o) dextrose bolus gbãtɔa ŋu be woaxe mɔ ɖe Wernicke tagbɔdɔléle sesẽ nu.

2. Octreotide (Sandostatin) ƒe Dɔwɔɖoɖo Tɔxɛ Kple Atike Siwo Dona Ðe Ame Ŋu ƒe Titration si Yia Edzi¶

Ne èɖɔ suklidɔ ƒe dzidziɖedzi gbãtɔ ŋutɔ ɖo vɔ teti (alo ne èva ɖo enumake ne EMS do ŋgɔ na kɔdziyiyi do IV dextrose alo sukli si woano xoxo ɖe ʋumesukli ƒe agbɔsɔsɔ si bɔbɔ si woŋlɔ ɖi ta) la, dze Octreotide gɔme:

1. Agbɔsɔsɔme Siwo Wozãna Le Lãmetsi Te (SC) alo To Ʋuka Me (IV) (Standard First-Line Protocol):
2. Ame tsitsiwo: 50 mcg to 100 mcg le ŋutigbalẽ te (SC) alo blewu le ʋuka me (IV) gaƒoƒo 6 ɖesiaɖe hena gaƒoƒo 24 ya teti. (Dɔdaƒe ƒe aɖaŋuɖoɖo: Atike dodo ɖe ŋutigbalẽ te naa depot effect si nɔa bɔbɔe, si nɔa anyi didi le gaƒoƒo 6 va ɖo 8 me eye wòƒoa asa na ʋuʋudedi kpui alo dzitodzito ƒe ʋuʋu si wokpɔna ɣeaɖewoɣi ne wotsɔ IV tutu kabakaba).
3. Ðeviwo ƒe Dɔnɔwo: 1 to 1.5 mcg/kg (vaseɖe esi sɔ gbɔ wu 50 mcg le agbɔsɔsɔme ɖesiaɖe me) le ŋutigbalẽ te (SC) alo IV gaƒoƒo 6 ɖesiaɖe hena gaƒoƒo 24 ya teti.
4. Octreotide Dodo Ðe Ʋuka Me Atraɖii (Na Suklidɔ Gã Siwo Woɖoe koŋ Dona Alo Suklidɔ si Womeɖe Mɔ Na O):
5. Ne dɔnɔ aɖe mi Glucotrol XL alo Glyburide ƒe atikekui gbogbo aɖewo siwo woɖena ɖe go ɣeyiɣi didi eye wòyi edzi le ʋumesukli ƒe ɖiɖi kpɔm le ɣeyiɣi aɖewo dome Q6H agbɔsɔsɔmewo, na gbãtɔ ** .50 to 100 mcg IV bolus** ( .1 to 1.5 mcg/kg le ɖeviwo me) si kplɔe ɖo enumake kple IV Octreotide dodo atraɖii le 25 mcg/hour to 50 mcg/hour le ame tsitsiwo me (alo 50 to 125 ng/kg/minute [3 to 7.5 mcg/kg/hour] le ɖeviwo me).
6. Dɔgbome ƒe ɖiƒoƒo ɖeɖeɖa na atikekui siwo woɖena ɖe go enumake tsɔ wu esiwo woɖena ɖe go didi (Glucotrol XL):
7. Atike Si Wozãna Ðekae (1 g/kg, max 50 g): Doe to nu me ne dɔnɔa va le gaƒoƒo 1 va ɖo 2 me tso esime wònoe eye wònyɔ bliboe eye wòle woƒe yaƒoƒomɔ̃a ta kpɔm.
8. Extended-Release Glipizide (Glucotrol XL) "GITS" Osmotic Pump Shells: Glucotrol XL zãa cellulose-acetate membrane si wotsɔ laser-ku si womate ŋu axɔ o (Gastrointestinal Therapeutic System, GITS) si tsɔa glipizide doa goe vivivi le gaƒoƒo 16 va ɖo 24 me abe alesi wòle ene toa dɔgbo bliboa me. Le Glucotrol XL ƒe agbɔsɔsɔ gã si woɖo koŋ zã wògbɔ eme me la, na Activated Charcoal vaseɖe gaƒoƒo 4 va ɖo 6 le eɖuɖu vɔ megbe eye nàbu Whole-Bowel Irrigation (WBI) kple Polyethylene Glycol Electrolyte Solution (PEG-ES le 1.5 to 2 L/hr le ame tsitsiwo me alo 25 mL/kg/hr le ɖeviwo me) be woatsɔ akɔ osmotic pɔmpi ƒe go siwo mexɔ o la ado goe le dɔgboa me.

3. Atike-Atike Kple Ayiku ƒe Nu Vevi 6 Siwo Naa Sulfonylurea Coma Na Ame Tsitsiwo¶

Dɔnɔ siwo wu 70 le alafa me siwo woxɔna ɖe kɔdzi le sulfonylurea ƒe suklidɔ ƒe ɖiɖi sesẽ ta le ame tsitsi siwo xɔ wu ƒe 65 me la dzɔna le dɔnɔ siwo noa woƒe agbɔsɔsɔ si woŋlɔ na wo edziedzi siwo doa go nu ade siwo nana suklidɔa nu sẽna la dometɔ ɖeka:

1. CYP2C9 Enzyme Mɔxenuwo (Bactrim, . Fluconazole, . Metronidazole, . Amiodarone): Aklã me cytochrome P450 CYP2C9 ye nye enzyme vevitɔ si trɔa glipizide, glyburide, glimepiride, kple tolbutamide. Ne wodze ŋkeke 5 ƒe trimethoprim-sulfamethoxazole (Bactrim / Septra) zazã gɔme na aɖuɖɔtoedɔléle alo fluconazole (Diflucan) na amɔwɔʋãnu ƒe dɔléle la, edzia sulfonylurea ƒe ʋu me agbɔsɔsɔ ɖe edzi 200% va ɖo 400% le gaƒoƒo 48 me.
2. Fluoroquinolone Dɔlékuiwutikewo (Ciprofloxacin, . Levofloxacin, . Moxifloxacin): Xexe mɔ na dɔgbo ƒe beta-lãmenugbagbeviwo tẽ K-ATP channels alongside sulfonylureas EYE xea mɔ na CYP enzymes, si hea suklidɔ si nu sẽ kpata, si xɔ ŋkɔ be esẽna kple suklidɔ ƒe alɔ̃madɔmadɔ (si tsɔ FDA ƒe Nuxlɔ̃ame si le Aɖaka me) vɛ.
3. Gemfibrozil + Repaglinide (CYP2C8 + OATP1B1 Blockade): Ne èno ʋumemi si me ʋumemi le gemfibrozil (Lopid) kpe ɖe meglitinide repaglinide (Prandin) ŋu la, enaa repaglinide ƒe agbɔsɔsɔ le ʋu me dzina ɖe edzi zi gbɔ zi zi gbɔ zi 8.1 (810%) eye wòdidia eƒe afã ƒe agbenɔƒe tso gaƒoƒo 1 va ɖo gaƒoƒo 12 kple edzivɔ; ne itraconazole hã le eme la, eƒe agbɔsɔsɔ dzina ɖe edzi zi gbɔ zi 19.
4. Beta-Blockers Siwo Metiaa O (Propranolol, . Nadolol, . Carvedilol): Mitsyɔ nu veveseseɖeamenu ƒe adrenergic ƒe nuxlɔ̃amedzesi gbãtɔ siwo fia be sukli si le ɖiɖim (si xea mɔ na ʋuʋudedi, dzi ƒe tsotso, kple dzimaɖitsitsi, esime nègblẽa cholinergic fifia [diaphoresis] ɖi) eye le ɣeyiɣi ma ke me la, xea mɔ na beta-2-tomemɔfiame aklã ƒe glycogenolysis, ale be dɔnɔa nadzo tẽ tso alesi wòse le eɖokui me be yeƒe lãme sẽ me yi neuroglycopenic kpata coma nuxlɔ̃ame manɔmee.
5. Salicylate (Aspirin) ƒe agbɔsɔsɔ fũ alo NSAID ƒe agbɔsɔsɔ gã: Ðe sulfonylureas ɖa le plasma albumin ƒe kadodo teƒewo eye wòʋãa insulin ƒe dodo tẽ esime wòle mɔ xem na gluconeogenesis.
6. Ayiku ƒe Nuveviwɔame Sesẽ (AKI) alo ayikudɔléle si nɔa anyi didi si yia ŋgɔ (CKD): Togbɔ be glipizide trɔna le aklã me wòzua nusiwo mewɔa dɔ o hã la, glyburide (glibenclamide) kple glimepiride trɔna zua hydroxylated metabolites siwo wɔa dɔ (4-trans-hydroxyglyburide kple M1) siwo nɔa te ɖe ayiku dzi bliboe hena wo ɖeɖe ɖa. Ne ame tsitsi aɖe si le glyburide zãm la ƒe tsikuɖiɖi vie tso dɔlékui ƒe dɔgbo ƒe dɔléle gbɔ alo dze ACE inhibitor/NSAID zazã gɔme la, metabolite mawo siwo le dɔ wɔm la ƒoa ƒu hena ŋkeke 3 va ɖo 5, si wɔnɛ be suklidɔ ƒe ɖiɖi si nu metsina o.

Ʋɔnudrɔ̃ƒe ƒe Kpekpeɖeŋu: Vovototodede Sulfonylurea ƒe agbɔsɔsɔ si gbɔ eme kple Insulin si wodona ɖe gota dome (Insulin vs. C-Peptide) .¶

Ne ame tsitsi alo ɖevi aɖe va kple suklidɔ si me mekɔ o, si me womeɖea fu na o (blood glucose < 40 mg/dL) eye atikekui nono ŋutinya si me kɔ aɖeke meli o, ne woɖe ʋuka ɖeka si sɔ gbɔ wu si le etame dzĩ/tame dama le suklidɔ ƒe ɣeyiɣia me (do ŋgɔ alo le ɖusime esime wona IV Dextrose) na Serum Insulin, C-Peptide, Beta-Hydroxybutyrate, kple Sulfonylurea Toxicology Screen kpɔa dɔlélea gbɔ enumake:

• Endogenous Pancreatic Hyperinsulinemia (Sulfonylurea / Meglitinide Overdose OR Insulinoma): Elabena dɔnɔa ŋutɔ ƒe dɔgbo ƒe beta lãmenugbagbeviwo wɔa proinsulin, si ma 1:1 ɖe Insulin molecule 1 + C-Peptide molecule 1 me, Serum Insulin KPL Serum C-Peptide molecule evea siaa nye WODO KƆKƆE wòdze ƒã (Insulin > 3 mcIU/mL kple C-Peptide > 0.6 ng/mL le suklidɔ ƒe ɖiɖiɣi), eye ʋumenugbagbeviɣi/aɖuɖɔ me Sulfonylurea Screen ɖee fia be enyo.
• Exogenous Pharmaceutical Insulin Injection (Factitious / Malicious / Accidental Insulin Overdose): Wokɔa insulin siwo wodona ɖe asi me (Humulin, Novolog, Lantus, Humalog) ŋu C-peptide manɔmee, eye insulin si wodo la tea dɔnɔa ŋutɔ ƒe dɔgbo ɖe to. Eyata Serum Insulin nye SKY-HIGH esime Serum C-Peptide nye SUPRESSED / UNDETECTABLE (< 0.2 ng/mL).

Nutome ƒe xexlẽdzesi siwo ku ɖe nudzɔdzɔ kpatawo ŋu kple dɔwɔƒea ƒe ɖoɖowo¶

Nya siwo wobiaa amewo enuenu¶

Nukatae Dextrose (D50W) sukli si woda le eɖokui si nana dɔnɔa ƒe ʋumesukli gagblẽna ɖe edzi le miniti 30 megbea?¶

Le sulfonylurea ƒe agbɔsɔsɔ si gbɔ eme me la, woblaa atike la ɖe dɔgboa ƒe beta lãmenugbagbeviwo ŋu sesĩe, eye wòléa woƒe potassium-mɔwo ɖe te ale be wodzraa dɔgboa ɖo be wòaɖe insulin ɖa atraɖii. Ne ɖɔkta alo kpekpeɖeŋunala aɖe ƒo Dextrose (D50W) ƒe bolus si me wode 50% si me wodea nu ƒui ɖe ʋuka aɖe me evɔ metsɔ Octreotide na o la, sukli si dzina ɖe edzi kpata le ʋu me la yɔa dɔgboa ƒe beta lãmenugbagbeviwo me eye wòhea insulin yeye ŋutɔ ƒe dodo ƒe dzidziɖedzi gã aɖe si wowóna vɛ. Le aɖabaƒoƒo 30 va ɖo 60 me la, insulin ƒe ƒutsotsoe gã ma si gbugbɔna la tutua sukli si wodo na dɔnɔa katã eye wònana dɔnɔa ƒe ʋumesukli gaɖiɖi va ɖoa eƒe agbe afɔku me.

Aleke Octreotide xea mɔ na sukli si bɔbɔ ɖe ʋu me le Glipizide alo Glyburide ƒe agbɔsɔsɔ fũ me?¶

Octreotide nye dzɔdzɔmeŋusẽ si nye somatostatin ƒe akpa aɖe si wowɔ. Togbɔ be sulfonylureas abe glipizide kple glyburide zi dɔgboa ƒe beta lãmenugbagbevi ƒe potassium mɔwo dzi be woatu le elektrikŋusẽmɔa ƒe gɔmedzedze hã la, beta lãmenugbagbevi la mate ŋu aɖe insulin ɖa kokoko o negbe ɖe calcium ions si to calcium mɔ siwo ŋu elektrikŋusẽ ƒe agbo le le mɔa ƒe nuwuwu me hafi. Octreotide blana ɖe somatostatin xɔlawo ŋu le beta lãmenugbagbevi la dzi eye wòtua calcium mɔ mawo siwo ŋu elektrikŋusẽ ƒe agbo le le anyime tẽ - si tsia dɔgboa me insulin ƒe dodo le aɖabaƒoƒo ʋɛ aɖewo me esime sulfonylurea atikekui la gakpɔtɔ le ŋutilãa me gɔ̃ hã.

Nukatae ɖɔkta mate ŋu adze sukli si wodona ɖe ʋuka me si woatsɔ axe mɔ ɖe dɔlélea nu gɔme o (D5W alo D10W) enumake ɖe vidzĩ si le zɔzɔm si ɖewohĩ mi Glipizide-tike gake sukli si sɔ le ʋu me gakpɔtɔ le eŋu la dzia?¶

Ne wokplɔ ɖevi sue aɖe va xɔ si me wowɔa dɔ kpata le esi wokpɔ glipizide alo glyburide ƒe aŋetu si le ʋuʋu ɖi vɔ la, zi geɖe la, ɖɔktawo menyae kple kakaɖedzi nenye be ɖevia mi atikekui aɖe ŋutɔŋutɔ alo ɖeko wòdae ɖe anyigba o. Ne ɖɔkta aɖe tsɔ ɖevi si me dzesi aɖeke mele o la bla ɖe dextrose si wotsɔ xea mɔ na dɔlélea ŋu alo na Octreotide enumake esime sukli si le ʋu me la sɔ la, tsi si le dodom la atsyɔ ʋumesukli ƒe ɖiɖi dzi gaƒoƒo geɖe, si ana ƒuƒoƒoa naƒo nya ta alakpatɔe be womemi atikekui aɖeke o eye woaɖe ɖevia ayi aƒeme abe alesi atikekui la ɖo eƒe kɔkɔƒe ene - alo abia ŋkeke geɖe be wòanɔ kɔdzi madzemadzee. Ke boŋ woxɔa ɖevi siwo me dzesi aɖeke mele o ɖe nuɖuɖu si sɔ dzi gaƒoƒo 24 si me sukli si wodona ɖe ʋuka me mele o dzi esime wole asibidɛ ƒe ʋumesukli ƒe ʋu me dzrom gaƒoƒo 1 va ɖo 2 ɖesiaɖe, wodzea Dextrose kple Octreotide dodo ɖe ʋu me gɔme enumake ne eɖiɖi ŋutɔŋutɔ si mede 60 va ɖo 70 mg/dL o.

Nukatae ame tsitsi siwo no Glyburide alo Glimepiride ƒe agbɔsɔsɔ ɖeka dedie ƒe geɖe la gena ɖe suklidɔ ƒe alɔ̃madɔmadɔ me zi ɖeka ne wodze dɔlékuiwutike si nye Bactrim (Trimethoprim-Sulfamethoxazole) alo Fluconazole zazã gɔme vɔ?¶

Sulfonylureas abe glipizide, glyburide, kple glimepiride ene mãna le aklã me to cytochrome P450 enzyme CYP2C9 dzi eye ayiku me ʋukawo tsɔa wo doa goe. Dɔlékuiwutike kple fungiwutike siwo bɔ - vevietɔ Sulfamethoxazole-Trimethoprim (Bactrim/Septra), Fluconazole (Diflucan), Metronidazole, kple Fluoroquinolones (ciprofloxacin, levofloxacin) - xea mɔ na CYP2C9 enzyme la vevie eye wòxea mɔ na ayiku ƒe ʋuʋu, si wɔnɛ be dɔnɔa ƒe gbesiagbe suklidɔ ƒe atikekui si sɔ la ƒoa ƒu ɖe eme ʋua va ɖoa eƒe agbɔsɔsɔ si sɔ ƒe teƒe 3 va ɖo 5 eye wòhea suklidɔ ƒe alɔ̃madɔmadɔ sesẽ si nɔa anyi didi vɛ.

Nukatae wòle be dɔnɔ nanɔ kɔdzi gaƒoƒo 12 va ɖo 24 bubu NE wodzudzɔ woƒe Octreotide dodo kple sukli si wodona le ʋuka me vɔ megbe?¶

Octreotide ƒe afã ƒe agbenɔƒe nye gaƒoƒo ʋɛ aɖewo ko, gake sulfonylureas le agbɔsɔsɔ si gbɔ eme me (vevietɔ Glipizide XL si woɖena ɖe go ɣeyiɣi didi, Chlorpropamide si wɔa dɔ ɣeyiɣi didi, alo Glyburide kple Glimepiride ƒe metabolite siwo wɔa dɔ le dɔnɔ siwo ƒe ayiku ƒe dɔwɔwɔ dzi ɖe kpɔtɔ me) ate ŋu anɔ dɔgboa ŋu gaƒoƒo 36 va ɖo 72+. Togbɔ be dɔnɔa le Octreotide xɔm gaƒoƒo 6 ɖesiaɖe hã la, woƒe ʋumesukli adze abe ɖe wòsɔ keŋkeŋ ene elabena Octreotide le dɔgboa lém. Mɔ ɖeka kolia si dzi woato aɖo kpe edzi be sulfonylurea la kɔ ŋutilãa ŋu mlɔebae nye be woadzudzɔ Octreotide kple IV dextrose zazã eye woalé ŋku ɖe dɔnɔa ŋu le nuɖuɖu edziedzi ɖeɖeko me gaƒoƒo 12 va ɖo 24 blibo be woakpɔe ɖa be suklidɔa megagbugbɔna o.

Mɔfiame siwo do ƒome kplii¶

• Suklidɔ ƒe nɔnɔme kpatawo: suklidɔ ƒe dzidziɖedzi kple suklidɔ ƒe agbɔsɔsɔ fũ ƒe kpekpeɖeŋunana gbãtɔ
• Suklidɔ ƒe ketoacidosis (DKA) kple hyperosmolar hyperglycemic nɔnɔme (HHS) .
• Status epilepticus, alɔ̃madɔmadɔ ɣeyiɣi didi, kple xɔnametikewo
• Ayiku ƒe abixɔxɔ sesẽ, rhabdomyolysis, kple aɖuɖɔtoe ƒe vovototodedeameme viviti
• Aɖi ƒe kpekpeɖeŋunana gbãtɔ kple aɖidzikpɔkpɔ ƒe vovototodedeameme

Dzɔtsoƒewo kple dziɖuɖumegãwo ƒe mɔfiame¶

• Amerikatɔwo ƒe Atikewɔwɔ ƒe Aɖiŋutinunya ƒe Kɔledzi (ACMT) & Amerika ƒe Aɖi Dɔwɔƒewo: Mɔfiame si Wotu Ðe Kpeɖodziwo Dzi le Sulfonylurea Nono ƒe Dɔwɔnawo Dzi Kpɔkpɔ le Kɔdzi Godo kple Mɔfiame Siwo Ku Ðe Octreotide Ŋu le Atike Siwo Wozãna Ðe Nudzraɖoƒe Ŋu.
• Amerika Suklidɔ Habɔbɔ (ADA) & Endocrine Society: Suklidɔ ƒe Belélename ƒe Dzidzenuwo: Ame Tsitsiwo kple Ðeviwo ƒe Suklidɔ ƒe Dɔlélewo Kple Sulfonylurea ƒe Aɖi ƒe Dzodzro Kple Wo Dzi Kpɔkpɔ.
• Fiaɖuƒea ƒe Atikewɔwɔ Kpata ƒe Kɔledzi (RCEM) & Dukɔa ƒe Aɖi Ŋuti Nyatakaka Dɔwɔƒe (NPIS, United Kingdom): TOXBASE Dɔdamɔnu ƒe Ðoɖowɔɖi na Sulfonylurea ƒe agbɔsɔsɔme si gbɔ eme kple Octreotide ƒe Dɔlékuiwutike ƒe Ƒomedodo A ƒe Nudzraɖoƒe.
• Extracorporeal Treatments in Poisoning (EXTRIP) & Clinical Toxicology Collaborative: Ðeviwo ƒe "Atikekui Ðeka Ate Ŋu Awu" Mɔfiame: Gaƒoƒo 24 ƒe ŋkuléle ɖe nu ŋu si nye Sedziwɔwɔ kple Octreotide Xɔname le Sulfonylurea ƒe Dɔlélewo Me.
• Xexeame ƒe Lãmesẽ Habɔbɔ (WHO): Kpɔɖeŋu ƒe Atikewɔwɔ Kple Suklidɔ ƒe Dɔléle Sesẽwo Dzikpɔkpɔ tso Insulin Secretagogues (Glibenclamide / Gliclazide) siwo Wono me.

--- .

Mɔfiame sia nye nyatakaka nana eye mexɔ ɖe atikewɔlawo ƒe atikewɔwɔ kpata ƒe dodokpɔ, Aɖidzikpɔkpɔ ƒe aɖaŋuɖoɖo, alo kɔdzi ƒe ŋkuléle ɖe dɔnɔwo ŋu teƒe o. Esi wònye be sulfonylurea ƒe atikekui ɖeka ate ŋu ana suklidɔ natsi megbe, enuenu, eye wòanɔ alɔ̃ me ta la, míele aɖaŋu ɖom vevie be nàwɔ kpekpeɖeŋunadɔ gbãtɔ kple CPR ƒe hehexɔxɔ si ŋu woda asi ɖo to Dukɔwo Dome Atitsoga Dzĩ Habɔbɔ kple Ɣleti Dzĩ Habɔbɔwo ƒe Habɔbɔ (IFRC), miaƒe dukɔa ƒe Atitsoga Dzĩ Habɔbɔ, St John Ambulance, alo nutoa me dɔwɔƒe si ŋu woɖo kpee dzi.